BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamada M, Yura Y. Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.Int J Mol Sci. 2020;21. [PMID: 32992948 DOI: 10.3390/ijms21197073] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang C, Dong T, Phung AT, Shah JR, Larson C, Sanchez AB, Blair SL, Oronsky B, Trogler WC, Reid T, Kummel AC. Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus. ACS Biomater Sci Eng 2022. [DOI: 10.1021/acsbiomaterials.2c00966] [Reference Citation Analysis]
2 Pereira D, Martins D, Mendes F. Immunotherapy in Head and Neck Cancer When, How, and Why? Biomedicines 2022;10:2151. [DOI: 10.3390/biomedicines10092151] [Reference Citation Analysis]
3 Zhang Y, Nagalo BM. Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We? Front Immunol 2022;13:898631. [DOI: 10.3389/fimmu.2022.898631] [Reference Citation Analysis]
4 Martín-carrasco C, Delgado-bonet P, Tomeo-martín BD, Pastor J, de la Riva C, Palau-concejo P, del Castillo N, García-castro J, Perisé-barrios AJ. Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. Veterinary Sciences 2022;9:327. [DOI: 10.3390/vetsci9070327] [Reference Citation Analysis]
5 Zhou L, Zou M, Xu Y, Lin P, Lei C, Xia X. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics. Front Oncol 2022;12:864301. [PMID: 35664731 DOI: 10.3389/fonc.2022.864301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li Q, Oduro PK, Guo R, Li R, Leng L, Kong X, Wang Q, Yang L. Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors. Front Cell Infect Microbiol 2022;12:921534. [DOI: 10.3389/fcimb.2022.921534] [Reference Citation Analysis]
7 Parmar K, Mohamed A, Vaish E, Thawani R, Cetnar J, Thein K. Immunotherapy in head and neck squamous cell carcinoma: An updated review. Cancer Treatment and Research Communications 2022;33:100649. [DOI: 10.1016/j.ctarc.2022.100649] [Reference Citation Analysis]
8 Feng G, Wang T, Xue F, Qi Y, Wang R, Yuan H. Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma. Head Neck 2021;43:3820-31. [PMID: 34569097 DOI: 10.1002/hed.26877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Santos Apolonio J, Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Silva Souza JV, Rocha Pinheiro SL, de Souza WR, Sande Loureiro M, de Melo FF. Oncolytic virus therapy in cancer: A current review. World J Virol 2021; 10(5): 229-255 [PMID: 34631474 DOI: 10.5501/wjv.v10.i5.229] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
10 Liu H, Luo H. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Viruses 2021;13:1082. [PMID: 34198859 DOI: 10.3390/v13061082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Abd-Aziz N, Poh CL. Development of oncolytic viruses for cancer therapy. Transl Res 2021:S1931-5244(21)00104-3. [PMID: 33905949 DOI: 10.1016/j.trsl.2021.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Teijeira Crespo A, Burnell S, Capitani L, Bayliss R, Moses E, Mason GH, Davies JA, Godkin AJ, Gallimore AM, Parker AL. Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity. Immunology 2021;163:389-98. [PMID: 33638871 DOI: 10.1111/imm.13323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Menotti L, Avitabile E. Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy.Int J Mol Sci. 2020;21. [PMID: 33167582 DOI: 10.3390/ijms21218310] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]